These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4772055)

  • 41. Effects of delta9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture.
    White AC; Munson JA; Munson AE; Carchman RA
    J Natl Cancer Inst; 1976 Mar; 56(3):655-8. PubMed ID: 943561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil.
    Ten Ham M; Loskota WJ; Lomax P
    Eur J Pharmacol; 1975 Mar; 31(1):148-52. PubMed ID: 1126373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabidiol interaction with delta9-tetrahydrocannabinol.
    Borgen LA; Davis WM
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):663-70. PubMed ID: 4828762
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of delta9-tetrahydrocannabinol on the rates of oxygen consumption of mice.
    Pertwee RG; Tavendale R
    Br J Pharmacol; 1977 Aug; 60(4):559-68. PubMed ID: 907869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects on visual tracking of delta9-tetrahydrocannabinol and pentobarbital.
    Stoller K; Swanson GD; Bellville JW
    J Clin Pharmacol; 1976; 16(5-6):271-5. PubMed ID: 1262537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of 1-delta9-tetrahydrocannabinol, dl-amphetamine and pentobarbital on oxygen consumption by mouse brain and heart homogenates.
    Dembert ML; Harclerode J
    Biochem Pharmacol; 1974 Mar; 23(5):947-56. PubMed ID: 4458679
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of oral administration of delta9 tetrahydrocannabinol on memory, speech, and perception of thermal stimulation: results with four normal human volunteer subjects. Preliminary report.
    Zeidenberg P; Clark WC; Jaffe J; Anderson SW; Chin S; Malitz S
    Compr Psychiatry; 1973; 14(6):549-56. PubMed ID: 4764355
    [No Abstract]   [Full Text] [Related]  

  • 48. Retardation of discrimination reversal by delta9-tetrahydrocannabinol in monkeys.
    Gluck JP; Ferraro DP; Marriott RG
    Pharmacol Biochem Behav; 1973; 1(6):605-8. PubMed ID: 4206607
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol.
    Karniol IG; Carlini EA
    Pharmacology; 1973; 9(2):115-26. PubMed ID: 4713005
    [No Abstract]   [Full Text] [Related]  

  • 50. Cannabis-induced hypothermia: a dose-effect comparison of crude marihuana extract and synthetic 9 -tetrahydrocannabinol in male and female rats.
    Borgen LA; Lott GC; Davis WM
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):621-6. PubMed ID: 4701259
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption.
    Chiu P; Karler R; Craven C; Olsen DM; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):267-86. PubMed ID: 1197914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats.
    Varma DR; Goldbaum D
    J Pharm Pharmacol; 1975 Oct; 27(10):790-1. PubMed ID: 241799
    [No Abstract]   [Full Text] [Related]  

  • 54. Cannabichromene and delta 9-tetrahydrocannabinol: interactions relative to lethality, hypothermia and hexobarbital hypnosis.
    Hatoum NS; Davis WM; Elsohly MA; Turner CE
    Gen Pharmacol; 1981; 12(5):357-62. PubMed ID: 6269951
    [No Abstract]   [Full Text] [Related]  

  • 55. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

  • 56. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of 9 -tetrahydrocannabinol and mescaline on self-stimulation.
    Bailey PT; Pradhan SN
    Neuropharmacology; 1972 Nov; 11(6):831-8. PubMed ID: 4638183
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms.
    Robichaud RC; Hefner MA; Anderson JE; Goldberg ME
    Pharmacology; 1973; 10(1):1-11. PubMed ID: 4751537
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of delta9-tetrahydrocannabinol on active avoidance acquisition and passive avoidance retention in rats with amygdaloid lesions.
    Pandina RJ; Musty RE
    Pharmacology; 1975; 13(4):297-308. PubMed ID: 1187754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analgesic effect of delta 9-tetrahydrocannabinol in the dog.
    Kaymakçalan S; Türker RK; Türker MN
    Psychopharmacologia; 1974 Feb; 35(2):123-8. PubMed ID: 4815113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.